// App-Quantinova.ai

: Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma

Researchers

Presenter

  • David Jackson

Principal Investigators

  • Cris Roxas

  • Louise Thompson

  • Mariana Fernandes

  • Linda Green

  • Joanne Kavanagh

  • Alexandra Nanzer-Kelly

  • Grainne DAncona

  • Brian Kent

Medical Centers

  • Guy’s Severe Asthma Centre, Guy’s & St Thomas’ Hospitals; King’s College London, London, United Kingdom

  • Guy's Severe Asthma Centre, Guy's & St Thomas' Hospitals, London, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Glucocorticoid

  • Benralizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved